Neos Therapeutics (NEOS) Reports Q4 Loss of $1.14/Share

Neos Therapeutics (NASDAQ: NEOS) reported Q4 EPS of ($1.14), versus ($0.57) reported last year. Revenue for the quarter came in at $3.5 million, versus $1.66 million reported last year.

For earnings history and earnings-related data on Neos Therapeutics (NEOS) click here.

You May Also Be Interested In

• Tesla touts acceleration of new models, but Q1 results fall short of estimates
• Visa (V) Tops Q2 EPS by 7c, offers guidance
• Steel Dynamics (STLD) Tops Q1 EPS by 16c